Endocannabinoid System-Mediated Mechanisms of Acupuncture for Pain, Pruritus and Comorbid Neuropsychiatric Symptoms: A Systematic Review

Authors

  • Xuehan Liu Department of Acupuncture and Moxibustion, Henan University of Chinese Medicine, Zhengzhou, China
  • Man Li School of Basic Medicine, Tongji Medical College, Key Laboratory of Neurological Diseases of Hubei Province and National Education Ministry, Huazhong University of Science and Technology, Wuhan 430030, China

DOI:

https://doi.org/10.54097/w8vbx312

Keywords:

Acupuncture, Endocannabinoid system, Pain, pruritus and neuropsychiatric disorders, Cell-type-specific mechanism.

Abstract

In chronic pain, pruritus, anxiety, and depression—highly comorbid neurological disorders characterized by neuroinflammation, central sensitization, and circuit dysfunction—the endocannabinoid system (ECS, comprising CB1/CB2/GPR55 receptors, endogenous ligands AEA/2-AG, and metabolic enzymes FAAH/MAGL) serves as a key regulatory hub modulating inflammatory processes, synaptic plasticity, and neuronal homeostasis. Here, we present a systematic review of preclinical studies from the past three years (2023–2026), integrating multi-level evidence of ECS-mediated acupuncture for the above disorders. Preclinical evidence has established that acupuncture precisely modulates the ECS at peripheral (activating fibroblast CB2R to inhibit mast cell degranulation and inflammatory cytokines; upregulating sensory neuronal CB1R to suppress Nav1.8/COX-2 pathways), spinal (CB2R promoting microglial M2 polarization to alleviate neuroinflammation; CB1R inhibiting glial TLR4/MyD88/TRAF6 cascades), and supraspinal levels (cell-type-specific CB1R in vlPAG/RVM/ACC bidirectionally regulating pain and itch; hippocampal CB2R/AEA and GPR55 pathways mediating antidepressant and anxiolytic effects). Notably, the ECS exhibits dynamic compensatory crosstalk with the opioid system—when TRPM8 is deleted, analgesia shifts to exclusive ECS reliance; moreover, the hypothalamic OX1R-CB1R pathway activated by PC6 (Neiguan) stimulation provides an opioid-independent, tolerance-free analgesic strategy. Current challenges include lack of standardized acupuncture parameters, species differences, and insufficient clinical translational evidence. This review synthesizes molecular, cellular, and circuit-level evidence to support the ECS as a core integrative target for acupuncture in pain, pruritus, anxiety, and depression, and calls for advancing standardized acupuncture regimens and clinical translation of ECS-targeted therapies.

Downloads

Download data is not yet available.

References

[1] Pham, D.T., et al., TRPM8's Role in the Shift Between Opioid and Cannabinoid Pathways in Electroacupuncture for Inflammatory Pain in Mice. Int J Mol Sci, 2024. 25(23): p. 13000. DOI: https://doi.org/10.3390/ijms252313000

[2] Lee, M.T., et al., Median Nerve Stimulation as a Nonpharmacological Approach to Bypass Analgesic Tolerance to Morphine: A Proof-of-Concept Study in Mice. J Pain, 2021. 22(3): p. 300–312. DOI: https://doi.org/10.1016/j.jpain.2020.09.003

[3] Wu, J., et al., Electroacupuncture Exerts Analgesic Effects by Restoring Hyperactivity via Cannabinoid Type 1 Receptors in the Anterior Cingulate Cortex in Chronic Inflammatory Pain. Mol Neurobiol, 2024. 61(5): p. 2949–2963. DOI: https://doi.org/10.1007/s12035-023-03760-7

[4] Shen, S.Y., et al., The neuroprotective effects of GPR55 against hippocampal neuroinflammation and impaired adult neurogenesis in CSDS mice. Neurobiol Dis, 2022. 169: p. 105743. DOI: https://doi.org/10.1016/j.nbd.2022.105743

[5] Tu, S.W., et al., Fibroblasts as key effectors of acupuncture in treatment of rheumatoid arthritis. Front Immunol, 2026. 17: p. 1715313. DOI: https://doi.org/10.3389/fimmu.2026.1715313

[6] Ge, W., et al., Electroacupuncture exerts antipruritic and anti-inflammatory effects on atopic dermatitis by activating CB2 receptor. Chin Med, 2025. 20(1): p. 72. DOI: https://doi.org/10.1186/s13020-025-01102-4

[7] Ho, T.J., et al., Electroacupuncture attenuates inflammatory pain via peripheral cannabinoid receptor type 1 signaling pathway in mice. PLoS One, 2023. 18(12): p. e0295432. DOI: https://doi.org/10.1371/journal.pone.0295432

[8] Yuan, X.C., et al., Electroacupuncture Potentiates Cannabinoid Receptor-Mediated Descending Inhibitory Control in a Mouse Model of Knee Osteoarthritis. Front Mol Neurosci, 2018. 11: p. 112. DOI: https://doi.org/10.3389/fnmol.2018.00112

[9] Ge, W.Q., et al., Electroacupuncture reduces chronic itch via cannabinoid CB1 receptors in the ventrolateral periaqueductal gray. Front Pharmacol, 2022. 13: p. 931600. DOI: https://doi.org/10.3389/fphar.2022.931600

[10] Wan, K., et al., Electroacupuncture produces analgesic effects via cannabinoid CB1 receptor-mediated GABAergic neuronal inhibition in the rostral ventromedial medulla. Chin Med, 2025. 20(1): p. 30. DOI: https://doi.org/10.1186/s13020-025-01083-4

[11] Chen, X.R., et al., Cannabinoid type 2 receptors play a crucial role in social defeat-induced depression. J Affect Disord, 2024. 348: p. 333–344. DOI: https://doi.org/10.1016/j.jad.2023.12.089

[12] Chen, Y.H., et al., Median nerve stimulation induces analgesia via orexin-initiated endocannabinoid disinhibition in the periaqueductal gray. Proc Natl Acad Sci U S A, 2018. 115(45): p. E10720–e10729. DOI: https://doi.org/10.1073/pnas.1807991115

[13] Hsiao, I.H., et al., Electroacupuncture Relieves Fibromyalgia Pain in a Female Mouse Model by Augmenting Cannabinoid Receptor 1 Expression and Suppressing Astrocyte and Microglial Activation in Nociceptive Pathways. Biomedicines, 2025. 13(9): p. 2112. DOI: https://doi.org/10.3390/biomedicines13092112

[14] Liu, Y., et al., Transcriptomic Profiling in Mice with CB1 receptor Deletion in Primary Sensory Neurons Suggests New Analgesic Targets for Neuropathic Pain. Front Pharmacol, 2021. 12: p. 781237. DOI: https://doi.org/10.3389/fphar.2021.781237

[15] Ma, N., et al., Electroacupuncture relieves visceral hypersensitivity through modulation of the endogenous cannabinoid system. Acupunct Med, 2023. 41(4): p. 224–234. DOI: https://doi.org/10.1177/09645284221107699

[16] Li, H., et al., Endocannabinoids regulate cocaine-associated memory through brain AEA-CB1R signalling activation. Mol Metab, 2022. 65: p. 101597. DOI: https://doi.org/10.1016/j.molmet.2022.101597

[17] Yuan, X.C., et al., Electroacupuncture potentiates peripheral CB2 receptor-inhibited chronic pain in a mouse model of knee osteoarthritis. J Pain Res, 2018. 11: p. 2797–2808. DOI: https://doi.org/10.2147/JPR.S171664

[18] Xia, F.Y., et al., [Effect of electroacupuncture on cannabinoid-related receptor CB2R and TRPV1 and spinal microglial polarization in rats with primary dysmenorrhea]. Zhen Ci Yan Jiu, 2025. 50(11): p. 1248–1256.

[19] Wang, Z., et al., Electroacupuncture inhibits mast cell degranulation via cannabinoid CB2 receptors in a rat model of allergic contact dermatitis. Acupunct Med, 2019. 37(6): p. 348–355. DOI: https://doi.org/10.1136/acupmed-2017-011506

[20] Zhang, H., et al., Electroacupuncture Reduces Visceral Pain Via Cannabinoid CB2 Receptors in a Mouse Model of Inflammatory Bowel Disease. Front Pharmacol, 2022. 13: p. 861799. DOI: https://doi.org/10.3389/fphar.2022.861799

[21] Chen, T., et al., Electro-acupuncture Pretreatment at Zusanli (ST36) Acupoint Attenuates Lipopolysaccharide-Induced Inflammation in Rats by Inhibiting Ca(2+) Influx Associated with Cannabinoid CB2 Receptors. Inflammation, 2019. 42(1): p. 211–220. DOI: https://doi.org/10.1007/s10753-018-0885-5

[22] Zhang, H., et al., Antagonism of cannabinoid receptor 1 attenuates the anti-inflammatory effects of electroacupuncture in a rodent model of migraine. Acupunct Med, 2016. 34(6): p. 463–470. DOI: https://doi.org/10.1136/acupmed-2016-011113

[23] Almeida, R.T., et al., Endocannabinoid mechanism for orofacial antinociception induced by electroacupuncture in acupoint St36 in rats. Pharmacol Rep, 2016. 68(6): p. 1095–1101. DOI: https://doi.org/10.1016/j.pharep.2016.07.004

[24] Du, J., et al., CB2R Attenuates Intervertebral Disc Degeneration by Delaying Nucleus Pulposus Cell Senescence through AMPK/GSK3β Pathway. Aging Dis, 2022. 13(2): p. 552–567. DOI: https://doi.org/10.14336/AD.2021.1025

[25] Cheng, X., et al., CB2-mediated attenuation of nucleus pulposus degeneration via the amelioration of inflammation and oxidative stress in vivo and in vitro. Mol Med, 2021. 27(1): p. 92. DOI: https://doi.org/10.1186/s10020-021-00351-x

[26] Jiang, Z., et al., Combined-Acupoint Electroacupuncture Induces Better Analgesia via Activating the Endocannabinoid System in the Spinal Cord. Neural Plast, 2022. 2022: p. 7670629. DOI: https://doi.org/10.1155/2022/7670629

[27] Yeh, Y.A., et al., Electroacupuncture Regulates Cannabinoid Receptor 1 Expression in a Mouse Fibromyalgia Model: Pharmacological and Chemogenetic Modulation. Life (Basel), 2024. 14(11): p. 1499. DOI: https://doi.org/10.3390/life14111499

[28] Hsiao, I.H., et al., Chemogenetic Modulation of Electroacupuncture Analgesia in a Mouse Intermittent Cold Stress-Induced Fibromyalgia Model by Activating Cerebellum Cannabinoid Receptor 1 Expression and Signaling. Life (Basel), 2025. 15(9): p. 1458. DOI: https://doi.org/10.3390/life15091458

[29] Hu, X.F., et al., Electroacupuncture alleviates chronic stress-induced anxiety via excitatory neuron CB1 receptor-dependent suppression of GR/SGK1 signaling in the mPFC. J Affect Disord, 2026. 403: p. 121242. DOI: https://doi.org/10.1016/j.jad.2026.121242

[30] Hu, X.F., et al., Electroacupuncture Reduces Anxiety Associated with Inflammatory Bowel Disease by Acting on Cannabinoid CB1 Receptors in the Ventral Hippocampus in Mice. Front Pharmacol, 2022. 13: p. 919553. DOI: https://doi.org/10.3389/fphar.2022.919553

Downloads

Published

15-11-2026

Issue

Section

Articles

How to Cite

Liu, X., & Li , M. (2026). Endocannabinoid System-Mediated Mechanisms of Acupuncture for Pain, Pruritus and Comorbid Neuropsychiatric Symptoms: A Systematic Review. International Journal of Biology and Life Sciences, 17(2), 239-250. https://doi.org/10.54097/w8vbx312